Guerville, F, Vialemaringe, M, Cognet, C, Duffau, P, Lazaro, E, Cazanave, C et al.. Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis. AIDS. 2023;37 (7):1035-1046. doi: 10.1097/QAD.0000000000003546. PubMed PMID:36928274 .
Silverberg, JI, Guttman-Yassky, E, Thaçi, D, Irvine, AD, Stein Gold, L, Blauvelt, A et al.. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. N Engl J Med. 2023;388 (12):1080-1091. doi: 10.1056/NEJMoa2206714. PubMed PMID:36920778 .
Izadi, Z, Gianfrancesco, MA, Schmajuk, G, Jacobsohn, L, Katz, P, Rush, S et al.. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study. Lancet Rheumatol. 2022;4 (9):e603-e613. doi: 10.1016/S2665-9913(22)00192-8. PubMed PMID:35909441 PubMed Central PMC9313519.
Blaye, C, Darbo, É, Debled, M, Brouste, V, Vélasco, V, Pinard, C et al.. An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy. ESMO Open. 2022;7 (4):100502. doi: 10.1016/j.esmoop.2022.100502. PubMed PMID:35759853 PubMed Central PMC9434232.
Picardo, M, Huggins, RH, Jones, H, Marino, R, Ogunsola, M, Seneschal, J et al.. The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol. 2022;36 (9):1507-1523. doi: 10.1111/jdv.18129. PubMed PMID:35366355 PubMed Central PMC9790455.
Poursac, N, Odriozola, I, Truchetet, ME. Strategy and Challenges of Paraclinical Examinations in Adult-Onset Still’s Disease. J Clin Med. 2022;11 (8):. doi: 10.3390/jcm11082232. PubMed PMID:35456325 PubMed Central PMC9027491.